These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13508)

  • 41. [Clinical study with a pure adrenergic beta receptors blocker in severe angina pectoris].
    Escudero J; Granados C
    Arch Inst Cardiol Mex; 1972; 42(4):572-9. PubMed ID: 4403727
    [No Abstract]   [Full Text] [Related]  

  • 42. [Angina pectoris--drug therapy and costs in a medical outpatient clinic in Switzerland].
    Banholzer C; Hess OM; Vetter W
    Schweiz Rundsch Med Prax; 1990 Dec; 79(49):1531-7. PubMed ID: 1979887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment with the preparation "Visken" (beta blocking agent) in angina pectoris].
    Mihail A; Popescu P; Petrescu X; Popa N
    Med Interna (Bucur); 1972 Aug; 24(8):925-32. PubMed ID: 4404181
    [No Abstract]   [Full Text] [Related]  

  • 44. Proceedings: Influence of perhexiline on the effort tolerance test in angina pectoris. Comparison with placebo and prenylamine.
    Cherchi A; Bina M; Fonzo R; Raffo M
    Postgrad Med J; 1973 Apr; 49():Suppl 3:67-74. PubMed ID: 4587035
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K
    Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical application of beta-blockaders].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1973 May; 117(21):814-21. PubMed ID: 4150242
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy and safety of nadolol in angina pectoris.
    Cruz J; Conceicao JM; Coelho EM
    Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
    [No Abstract]   [Full Text] [Related]  

  • 48. Perhexiline maleate in the treatment of angina pectoris. Five years of personal clinical experience.
    Wallace DC
    Med J Aust; 1978 Nov; 2(10):466, 493-5. PubMed ID: 33322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical study of delayed-action oxprenolol in the treatment of angina pectoris. Apropos of 21 cases].
    Fournier D
    Lille Med; 1981; 26(1-2):62-4. PubMed ID: 7206997
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term clinical results of oxprenolol in the treatment of cardiac arrhythmias, angina pectoris and hypertrophic subaortic stenosis.
    Scebat L; Bensaid J
    Postgrad Med J; 1970 Nov; ():Suppl:86-90. PubMed ID: 4395465
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm.
    Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén HN
    Cardiologia; 1995 Dec; 40(12 Suppl 1):301. PubMed ID: 8903053
    [No Abstract]   [Full Text] [Related]  

  • 52. [Remote results of treatment of angina pectoris with various types of drugs blocking beta adrenergic receptors].
    Musial W; Krzemińska-Pakula M; Tracz W
    Pol Tyg Lek; 1972 May; 27(20):752-4. PubMed ID: 4402234
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation, by the bicycle ergometry test ECG, of the efficacy of a single dosage of nadolol, in patients with stable angina pectoris].
    Capuano V; De Vita S; Riccio MD; De Martino M; Mondillo G
    Minerva Cardioangiol; 1985 Nov; 33(11):739-44. PubMed ID: 2868431
    [No Abstract]   [Full Text] [Related]  

  • 54. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of anaprilin and a glucose-insulin-potassium mixture on carbohydrate and lipid metabolic indices in unstable stenocardia].
    Bashmakova NV
    Vrach Delo; 1982 Jun; (6):53-7. PubMed ID: 6126046
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug therapy of coronary and myocardial insufficiency].
    Krüger K
    Ther Ggw; 1974 Apr; 113(4):584 passim. PubMed ID: 4832533
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of prenylamine on the QT interval of the resting electrocardiogram in patients with angina pectoris.
    Oakley D; Jennings K; Puritz R; Krikler D; Chamberlain D
    Postgrad Med J; 1980 Nov; 56(661):753-6. PubMed ID: 7267475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation of oxprenolol in angina pectoris.
    Sandler G; Pistevos A
    Br Heart J; 1972 Aug; 34(8):847-50. PubMed ID: 4560824
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug treatment of chronic stable angina pectoris.
    Rousel RH; Dodd G
    Br Med J; 1978 Mar; 1(6115):785. PubMed ID: 630351
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effectiveness of oxprenolol in depot form in stable angina pectoris].
    Langbehn A; Beurich HW; Sheikhzadeh A
    ZFA (Stuttgart); 1983 May; 59(14):840-3. PubMed ID: 6880357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.